The 2023 Women Science and Technology Innovation Pioneer Forum was held in Beijing on December 14, 2023. The forum was organized by Beijing Academy of Science and Technology, Beijing Women's Federation, Beijing Association for Science and Technology, and the ZGC Global High-Level Think Tank Alliance.
The purpose was to pool the strength of women scientists who have taken the lead in science and technology innovation, to deepen policy exchanges on women's participation in sci-tech innovation, and to promote the application of sci-tech advances.
During the forum, six sci-tech workers were granted the title of the Women Science and Technology Innovation Pioneer.
A project encouraging women's participation in STEM (science, technology, engineering and mathematics) in the APEC (Asia-Pacific Economic Cooperation) region, under the APEC Policy Partnership on Science, Technology and Innovation, was launched during the forum.
(Women of China English Monthly January 2024 issue)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
Browns, center Brian Allen agree to 1
Mainland a hot holiday attraction for HK tourists
More than 641 million parcels delivered over Spring Festival holiday
Space contractors release China's annual launch plan
Cynthia Erivo dazzles in black and white dress at the 49th Chaplin Awards ceremony in New York City
China prepares to launch space station core module
Xinjiang set to boost air trip business
China mulls sending spacecraft to edge of solar system: scientist
EDEN CONFIDENTIAL: Prince Harry's army friend JJ Chalmers urges Kate to talk about cancer
Founder of beverage giant Wahaha passes away at 79
Rangers' Max Scherzer scratched from 2nd scheduled rehab start because of sore thumb
Chinese inhibitor drug candidate becomes first to enter phase